Topix Pharmaceuticals, Inc., a leading provider of innovative therapeutic and cosmetic skin care products, recently announced that they have partnered with New Mountain Capital LLC, a growth-oriented investment firm that currently manages over $15 bi

Topix Pharmaceuticals, Inc., a leading provider of innovative therapeutic and cosmetic skin care products, recently announced that they have partnered with New Mountain Capital LLC, a growth-oriented investment firm that currently manages over $15 billion in assets. Headquartered in Amityville, New York, Topix has developed, manufactured, and marketed highly-innovative and clinically-validated topical skin care products for over 30 years.

Recognized by physicians for the high quality of its products, Topix is uniquely positioned due to its best-in-class formulation capabilities and proprietary product portfolio developed to meet the in-office dispensing needs of physicians and their patients. Topix’s product portfolio addresses a wide array of skin health conditions and customized, private label solutions for the professionally dispensed market. Topix utilizes their own state-of-the-art, GMP-compliant facilities to research, develop, manufacture, and test their products to the highest quality standards.